The use of post-ERCP pancreatitis prophylaxis and recognition of risk factors for post-ERCP pancreatitis among Dutch gastroenterologists: a nationwide practice survey
Completed
- Conditions
- Post-ERCP pancreatitis
- Registration Number
- NL-OMON22181
- Lead Sponsor
- Radboud university medical center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
BIG-registered physician specialized in gastroenterology
Exclusion Criteria
1.Non- gastroenterology physicians
2.Residents
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measure of this survey is exploration of the use and attitudes towards various forms of post-ERCP prophylaxis (NSAID use, prophylactic PD-stenting and IV hyperhydration) amongst Dutch biliary endoscopists.
- Secondary Outcome Measures
Name Time Method 1.Risk factor recognition for the development of post-ERCP pancreatitis<br>2.Guideline adherence to the 2019 ESGE Guidelines ‘ERCP related adverse events’<br>3.The presence and content of a post-ERCP pancreatitis prophylaxis protocol<br>4.Longitudinal comparison of answers from 2013 survey on the same subject by Dutch Pancreatitis Study Group (DPSG)<br>